Today: 20 May 2026
Browse Category

BSE:RRP 21 October 2025 - 19 December 2025

RRP Semiconductor’s 55,000% Stock Surge Triggers SEBI Scrutiny: Inside India’s Most Puzzling “Chip” Rally

RRP Semiconductor’s 55,000% Stock Surge Triggers SEBI Scrutiny: Inside India’s Most Puzzling “Chip” Rally

RRP Semiconductor shares surged over 55,000% in 20 months, rising from ₹15–₹20 to about ₹11,095 by December 2025, pushing its market value near ₹15,000 crore. SEBI has begun investigating the rally, while the BSE tightened trading rules. The company reported recent losses, negative revenue, and no active semiconductor manufacturing. Valuations reached extremes, with a negative P/E near -6,097 and a market-cap-to-sales ratio around 1,080.
19 December 2025
RRP Semiconductor Stock Skyrockets 57,000%; Sachin Tendulkar Link Debunked

Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

RRP Semiconductor Ltd shares soared from ₹15 in April 2024 to ₹9,478 on October 21, 2025, locking at the 2% upper circuit. The Bombay Stock Exchange imposed strict trading curbs, citing a price rise “not commensurate with the financials.” RRP denied rumors linking it to Sachin Tendulkar or government land. The company reported only a few crores in profit and has just two employees.
21 October 2025

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop